🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

David Lillicrap

Queen's University

ORCID: 0000-0003-2410-6312

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 16 papers. Top paper: “Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial”.

Effectiveness of therapeutic heparin versus prophylactic heparin on death, mechanical ventilation, or intensive care unit admission in moderately ill patients with covid-19 admitted to hospital: RAPID randomised clinical trial

BMJ(2021)10.1136/bmj.n2400

N/A

5.3DataRank · unranked

371 citations

Grace H. Tang, Hassan Rahhal, Musaad AlHamzah, Lisa Baumann Kreuziger, Fionnuala Ní Áinle +35 more

von Willebrand disease: advances in pathogenetic understanding, diagnosis, and therapy

Hematology(2013)10.1182/asheducation-2013.1.254

N/A

0.646DataRank · unranked

73 citations

David Lillicrap

Lipid nanoparticles and siRNA targeting plasminogen provide lasting inhibition of fibrinolysis in mouse and dog models of hemophilia A

Science Translational Medicine(2024)10.1126/scitranslmed.adh0027

N/A

0.559DataRank · unranked

19 citations

Woosuk S. Hur, Paul Batty, Yaqiu Sang, Sara R. Abrahams, Alyssa S. M. Yong +16 more

Suppression of anti-drug antibody formation against coagulation factor VIII by oral delivery of anti-CD3 monoclonal antibody in hemophilia A mice

Cellular Immunology(2023)10.1016/j.cellimm.2023.104675

N/A

0.312DataRank · unranked

7 citations

Roland W. Herzog, Sandeep Kumar, Alexandra Sherman, Jyoti Rana, Radosław Kaczmarek +7 more

Gut dysbiosis modulates the immune response to factor VIII in murine hemophilia A

Blood Advances(2020)10.1182/bloodadvances.2019001144

N/A

0.269DataRank · unranked

5 citations

Matthew Cormier, Kate Nesbitt, Courtney Dwyer, Christine Hough, David Lillicrap +1 more

R1205H (Vicenza) causes conformational changes in the von Willebrand factor D′D3 domains and enhances von Willebrand factor binding to clearance receptors LRP1 and SR-AI

Journal of Thrombosis and Haemostasis(2024)10.1016/j.jtha.2024.06.023

N/A

0.241DataRank · unranked

4 citations

Orla Rawley, Jamie M. O’Sullivan, Mehmet Özbil, Dearbhla Doherty, Niamh Cooke +10 more

Identification of multiple novel procoagulant plasma ligands for stabilin-2

Journal of Thrombosis and Haemostasis(2025)10.1016/j.jtha.2025.01.023

N/A

0.104DataRank · unranked

1 citations

Felipe da Veiga Leprevost, Venkatesha Basrur, Alexey I. Nesvizhskii, Orla Rawley, Krista Golden +4 more

Mice possess a more limited natural antihuman factor VIII antibody repertoire than humans that is produced disproportionately by marginal zone B cells

Journal of Thrombosis and Haemostasis(2023)10.1016/j.jtha.2023.08.033

N/A

0DataRank · unranked

1 citations

Erin Burnett, Aomei Mo, Colleen Notley, Nathalie Tijet, Natasha Christie-Holmes +3 more

Effect of age on ISTH-BAT scores and low VWF diagnosis in the Zimmerman Program

Blood Advances(2025)10.1182/bloodadvances.2025016725

N/A

0DataRank · unranked

5 citations

Pamela A. Christopherson, Dearbhla Doherty, Anne‐Marije Hulshof, Sandra L. Haberichter, Veronica H. Flood +11 more

Current Understanding of Inherited Modifiers of FVIII Pharmacokinetic Variation

Pharmacogenomics and Personalized Medicine(2023)10.2147/pgpm.s383221

N/A

0DataRank · unranked

10 citations

David Lillicrap, Laura L. Swystun

Recombinant Factor VIII Fc Inhibits B Cell Activation via Engagement of the FcγRIIB Receptor

Frontiers in Immunology(2020)10.3389/fimmu.2020.00138

N/A

0DataRank · unranked

8 citations

Paul Moorehead, Tongyao Liu, Jennifer Dumont, David W. Scott, Christine Hough +2 more

Immune complications and their management in inherited and acquired bleeding disorders

Blood(2022)10.1182/blood.2022016530

N/A

0DataRank · unranked

20 citations

David Lillicrap, Roland W. Herzog, Valder R. Arruda

Heterogeneity and reciprocity of FVIII and VWF expression, and the response to shear stress in cultured human endothelial cells

Journal of Thrombosis and Haemostasis(2022)10.1111/jth.15841

N/A

0DataRank · unranked

10 citations

Colleen Notley, Aomei Mo, Barbara Videl, David Lillicrap, Christine Hough

The contribution of the sinusoidal endothelial cell receptors CLEC4M, stabilin-2, and SCARA5 to VWF–FVIII clearance in thrombosis and hemostasis

Journal of Thrombosis and Haemostasis(2023)10.1016/j.jtha.2023.04.014

N/A

0DataRank · unranked

19 citations

Alison Michels, David Lillicrap, Laura L. Swystun

The common VWF variant p.Y1584C: detailed pathogenic examination of an enigmatic sequence change

Journal of Thrombosis and Haemostasis(2023)10.1016/j.jtha.2023.11.016

N/A

0DataRank · unranked

9 citations

Nathalie Tijet, Sandra L. Haberichter, Veronica H. Flood, Justyne E Ross, Colleen Notley +5 more

Tolerating Factor VIII: Recent Progress

Frontiers in Immunology(2020)10.3389/fimmu.2019.02991

N/A

0DataRank · unranked

70 citations

Jan Voorberg, David Lillicrap, David W. Scott, Kathleen P. Pratt, Sébastien Lacroix‐Desmazes